New Zealand - Hospital Average Length of Stay for Malignant Neoplasm of Uterus
Since 2014, New Zealand Hospital Average Length of Stay for Malignant Neoplasm of Uterus fell by 1.5% year on year. At 5.2 Days in 2019, the country was ranked number 22 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Uterus. New Zealand is overtaken by Chile, which was number 21 at 5.3 Days and is followed by Costa Rica with 5.1 Days. South Korea topped the ranking with 11.6 Days in 2019, that is a decrease of 0.9% compared to 2018. Latvia, Luxembourg and Germany respectively ranked number 2, 3 and 4 in this ranking. Luxembourg recorded the best 5 years average growth at +2.7% per year, while Iceland recorded the worst performance at -10.3% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 5.20 |
| 2018 | 5.50 |
| 2017 | 5.10 |
| 2016 | 7.40 |
| 2015 | 7.30 |
Download all data from 2000 to 2019
How does New Zealand rank in Hospital Average Length of Stay for Malignant Neoplasm of Uterus?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
11.60 | 2019 | -0.8 % | -0.2 % | View data | |
| 2 |
#2
Latvia
|
10.80 | 2019 | -0.9 % | -1.3 % | View data | |
| 21 |
#21
Chile
|
5.30 | 2019 | +0.0 % | +0.0 % | View data | |
| 22 |
#22
New Zealand
|
5.20 | 2019 | -5.5 % | -1.5 % | View data | |
| 23 |
#23
Costa Rica
|
5.10 | 2019 | -1.9 % | -2.5 % | View data | |